Kenvue Inc. Common Stock vs Vanguard Total World Stock Index Fund ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Vanguard Total World Stock Index Fund ETF trades at $159.9 (market cap $101.70B). The key difference: Vanguard Total World Stock Index Fund ETF is far larger — about 3× Kenvue Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Vanguard Total World Stock Index Fund ETF pays none. Which is the better fit depends on your goals.
| KVUE | VT | |
|---|---|---|
Market Cap | $34.06B | $101.70B |
Volume | 23,267,228 | 1,783,794 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $19.83 | $162.39 |
52-Week Low | $14.11 | $134.19 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 53 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Vanguard Total World Stock ETF (VT) trades at $159.83, up 0.12% on the day, with a bearish technical signal from moving averages. The ETF provides broad global equity diversification with over 9,700 holdings across developed and emerging markets. Recent news highlights its low 0.06% expense ratio and strong five-year performance compared to peers like Schwab International Equity ETF and iShares MSCI World ETF.
VT's outlook is supported by its cost efficiency and diversification benefits, though the bearish technical trend and potential trade war uncertainties pose near-term risks. The ETF remains a core holding for long-term investors seeking global exposure, with institutional activity showing mixed positioning amid market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →